Week |
Date |
Subject |
Instructor(s) |
Location |
1 |
W 1/17 |
Course Overview |
A. Rollins |
Wick TBD |
F 1/19 |
Introduction to Translational Research (TR) |
A. Rollins |
Wick TBD |
2 |
M 1/22 |
TR Case Example I |
J. Duerk |
Wick TBD |
W 1/24 |
Communication I – Group Communication |
K. Rothenberg |
Wick TBD |
F 1/26 |
Communications II – Giving & Receiving
Communication |
K. Rothenberg |
Wick TBD |
3 |
M 1/29 |
Communications III – Giving Directions
Activity |
K. Rothenberg |
Wick TBD |
W 1/31 |
Communications IV – Leadership & Conflict |
K. Rothenberg |
Wick TBD |
F 2/2 |
Communications V – Conflict Management |
K. Rothenberg |
Wick TBD |
4 |
M 2/5 |
Communications VI – Group Problem Solving
Activity |
K. Rothenberg |
Wick TBD |
W 2/7 |
Introduction to Translational Research (TR) |
A. Rollins |
Wick TBD |
F 2/9 |
TR Case Example II |
A. Rollins |
Wick TBD |
5 |
M 2/12 |
Research Ethics I – Scientific Misconduct |
C. Lamantia |
Wick TBD |
W 2/14 |
Research Ethics II – Conflict of
Interest |
E. Cottington |
Sears 642 |
F 2/16 |
Animal Research – Role, Ethics, IACUC |
M. Pagel |
Wick TBD |
6 |
M 2/19 |
Animal Models of CV Disease |
M. Penn |
Wick TBD |
W 2/21 |
TR Case Example III |
D. Dean |
Wick TBD |
F 2/23 |
Human Subjects I – Institutional
Review Boards |
P. Cola |
1400 Lakeside |
7 |
M 2/26 |
Human Subjects II – HIPAA & Consent |
P. Cola |
1400 Lakeside |
W 2/28 |
Human Subjects III – Good Clinical
Practices & FDA |
P. Cola |
1400 Lakeside |
F 3/2 |
Human Subjects IV – FDA & IDEs |
P. Cola |
1400 Lakeside |
8 |
M 3/5 |
Human Subjects V – Data Safety Monitoring |
P. Cola |
1400 Lakeside |
W 3/7 |
Mock IRB Meeting |
UH IRB Staff |
1400 Lakeside |
F 3/9 |
Risk Analysis |
D. Tyler |
Wick TBD |
|
M 3/12 |
Spring Break |
|
|
W 3/14 |
Spring Break |
|
|
F 3/16 |
Spring Break |
|
|
9 |
M 3/19 |
TR Case Example IV |
H. Peckham |
Wick TBD |
W 3/21 |
Clinical Trials I – Technology Maturity
/ Levels of Medical Evidence |
TBD |
Wick TBD |
F 3/23 |
Clinical Trials II – Health Technology
Assessment |
TBD |
Wick TBD |
10 |
M 3/26 |
Clinical Trials III – Comparative
Stats & Design of Clinical Experiments I |
TBD |
Wick TBD |
W 3/28 |
Clinical Trials IV – Comparative
Stats & Design of Clinical Experiments II |
TBD |
Wick TBD |
F 3/30 |
Clinical Trials V – Application
to Existing Project |
TBD |
Wick TBD |
11 |
M 4/2 |
TR Case Example V |
Mortimer + Onders |
Wick TBD |
W 4/4 |
Tech Transfer I – Introduction & Bayh
Dole Act |
M. Haag |
Wick TBD |
F 4/6 |
Tech Transfer II – Invention Disclosures |
M. Haag |
Wick TBD |
12 |
M 4/9 |
Tech Transfter III – Intellectual
Property |
G. Pitzer |
Wick TBD |
W 4/11 |
Tech Transfer IV - Entrepreneurship |
M. Haag |
Wick TBD |
F 4/13 |
Tech Transfer – work on group projects |
|
Wick TBD |
13 |
M 4/16 |
Invention Disclosure Presentations |
TT Office |
Wick TBD |
W 4/18 |
Tech Transfer V - Documentation |
D. Tyler |
Wick TBD |
F 4/20 |
TR Case Example VI |
D. Brown |
Wick TBD |
14 |
M 4/23 |
Work on Final Project |
|
Wick TBD |
W 4/25 |
TR Case Example VII |
B. Wessels |
Wick TBD |
F 4/27 |
TBD |
|
Wick TBD |
15 |
M 4/30 |
TBD |
|
Wick TBD |
TBD |
Final Project Presentations |
|
Wick TBD |
|
|
|
|
Rev 11/21/06 |
